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Preface
On February
16-17, 1999, in Arling-
ton, Virginia, 950 pub-
lic health officials, phy-
sicians, and other medi-
cal personnel, along
with government, mili-
tary, and intelligence
experts gathered for
the first National Symposium on Medical and
Public Health Response to Bioterrorism. Partici-
pants were geographically diverse. Represented
were 46 states, plus Washington, D.C., and 10
countries: Australia, Austria, Canada, England,
Finland, France, Germany, Israel, Italy, and the
Netherlands.
The guiding force behind the symposium was
the newly established Johns Hopkins Center for
Civilian Biodefense Studies, which hopes the
discussions will lead to a framework and
partnership for strategic planning. The other
main sponsors were the Department of Health
and Human Services, Infectious Diseases
Society of America, and American Society for
Microbiology. Twelve other public health
professional societies supported the conference.1
The list of speakers included D.A. Henderson,
director of the Johns Hopkins Center for Civilian
Biodefense Studies; Christopher J. Davis, former
senior intelligence analyst for chemical and
biological warfare matters on Britains Defense
Intelligence staff; Jessica Stern, Council on
Foreign Relations and author of the book The
Ultimate Terrorists; Joshua Lederberg, Nobel
laureate and professor and president emeritus of
Rockefeller University; Col. Gerald W. Parker,
director of the U.S. Army Medical Research
Institute of Infectious Diseases; Thomas V.
Inglesby and Tara OToole, Johns Hopkins
Center for Civilian Biodefense Studies; and
Philip K. Russell, Johns Hopkins School of Public
Health.
Federal, state, and local officials reflected on
the challenge of coordinating a multidisciplinary
and interagency response to a biological attack.
This array of speakers included Secretary of
Health and Human Services Donna Shalala;
Richard Clarke, National Security Council;
Michael Osterholm, Minnesota Department of
Health; and Jerry Hauer, director of New York
Citys Office of Emergency Management.
From their different backgrounds and
perspectives, the more than 20 speakers
addressed the following questions: Why are
current concerns about bioterrorism real? Why
must the medical and public health communities
address the issue of bioterrorism? Which
biological threats warrant the most concern?
What is the possible aftermath of an act of
biological terrorism?
A warning against complacency came from
the symposiums closing speaker, Margaret A.
Hamburg, assistant secretary for planning and
evaluation, U.S. Department of Health and
Human Services.
In making symposium presentations avail-
able here, the organizers hope to raise awareness
of the medical and public health threats posed by
biological weapons and to foster mutual
understanding and collaboration among the
diverse groups addressing the threat of
bioterrorism.
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